In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated ...
In my years as a nurse working in a drug detox unit, I’ve witnessed both the crushing grip of addiction and the grueling ...
Guilford County and local governments across the state are doing what they can to help substance abusers kick the habit – ...
16h
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...
The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain. LTG-001, an oral Nav1.8 selective ...
GlobalData on MSN22h
Lexicon’s non-opioid therapy for DPNP beats placebo in pain reductionThe company has chosen to move ahead to Phase III trials with its 10mg dose after it saw a 1.74-point reduction in pain score ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. | Lexicon Pharmaceuticals ...
Mexico has handled the cartels so poorly that it broke international law. It is obligated to prevent the harm cartels are ...
We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...
Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback